| Date | Title | Description | |
|---|---|---|---|
| 19 Apr 2024 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 12 April and 18 April 2024 | Download |
| 12 Apr 2024 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 5 April and 11 April 2024 | Download |
| 05 Apr 2024 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 28 March and 4 April 2024 | Download |
| 02 Apr 2024 | On business and financial situation | ROVI informs on the FDA’s approval of Risvan® as a treatment for schizophrenia | Download |
| 29 Mar 2024 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 22 March and 27 March 2024 | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 31 May 2017 | Convocatorias y Acuerdos de Juntas y Asambleas Generales | ROVI releases the information related to its General Shareholders Meeting | Download |
| 26 Apr 2017 | Convocatorias y Acuerdos de Juntas y Asambleas Generales | ROVI informs about the call for the 2017 Ordinary General Shareholders Meeting | Download |
| 21 Apr 2017 | Convocatorias y Acuerdos de Juntas y Asambleas Generales | ROVI informs about the call for the General Shareholders Meeting | Download |
| 21 Apr 2017 | Información sobre resultados | ROVI releases the press release related to the 2017 first quarter results. | Download |
| 21 Apr 2017 | Información sobre resultados | ROVI releases the presentation related to the 2017 first quarter results | Download |